Experts highlight how CRO-site partnerships advance phase III CV trials

Leveraging expedited programs in oncology: How accelerated approval helps drug developers get cancer drugs to patients faster

Fortrea's Alaric Jackson Talks AI in Clinical Trials

Fortrea’s Gani Chico Talks Oncology Innovation, AI and Clinical Trial Strategy

Optimize your product development journey and drive innovation with insightful guidance from our experienced global team

Flexible FSP resourcing meets evolving needs for an oncology biotech

Excellence in pharmacovigilance solutions: How Fortrea’s market-leading safety support enabled global operations for a leading pharmaceutical company

A framework for assessing the viability of an externally controlled arm for a single-arm trial

Jan Skoumal

• 26+ years of drug development experience specializing in immuno-oncology in Pharma/Biotech and CRO environments
• Provides operational executive leadership for Oncology study portfolio at Fortrea
• Chief Development Officer experi